CompletedNCT00221403
Valproate compared with risperidone for bipolarity in children ages 3–7
About this title
Read the official source — NCT00221403Medication studyAges 3–7United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 3 years to 7 years. Other eligibility criteria applied.
- Listed locations
- Cincinnati and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateSeptember 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 46
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 3 Years to 7 Years
- Official registry ID
- NCT00221403
- Official title
Show the full official title
Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati · Milwaukee
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Children's Hospital Medical Center, Cincinnati, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Risperidone oral solution and Valproate Oral Solution.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 3 years to 7 years. Other eligibility criteria applied.
